Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
Johnson & Johnson (NYSE: JNJ) will host an investor conference call on July 17th at 8:30 a.m. Eastern Time to discuss its second-quarter results. The call will be led by CEO Joaquin Duato, CFO Joseph J. Wolk, and VP of Investor Relations Jessica Moore, with other executive team members participating in the Q&A session. The webcast and presentation materials will be accessible on J&J's investor website, with a replay available three hours post-conference. U.S. participants can dial in at 877-869-3847, while international participants can use 201-689-8261. The replay will be available until August 14th, using the ID 13746915.
- J&J to host an investor conference call, indicating transparency and engagement with investors.
- Participation of top executives including CEO, CFO, and VP of Investor Relations, showcasing leadership involvement.
- Availability of webcast and presentation materials, enhancing accessibility for investors.
- Replay of the conference call available until August 14th, giving more time for investors to review.
- Lack of specific financial data or performance indicators in the PR.
- Depending on the Q2 results, any negative outcomes could impact stock performance.
Investors and other interested parties can access the webcast/conference call in the following ways:
- The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
-
By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the
U.S. is 877-869-3847. For participants outside theU.S. , the dial-in number is 201-689-8261. -
A replay of the conference call will be available until approximately 12:00 a.m. on August 14th. The replay dial-in number for
U.S. participants is 877-660-6853. For participants outside theU.S. , the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13746915. - The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
- Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the third-quarter date of Tuesday, October 15th, 2024.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604350189/en/
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
When will Johnson & Johnson's Q2 2024 investor conference call take place?
How can investors access Johnson & Johnson's Q2 2024 conference call?
Who will be hosting Johnson & Johnson's Q2 2024 investor conference call?